Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Hebart

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Current Opinion in Hematology|October 24, 2002
Cellular immunity to viral and fungal antigens after stem cell transplantationHermann Einsele, Holger Hebart
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 16, 2003
Specific infectious complications after stem cell transplantationHolger Hebart, Hermann Einsele
Human Immunology|June 3, 2004
CMV-specific immunotherapyHermann Einsele, Holger Hebart
Human Immunology|June 3, 2004
Clinical aspects of CMV infection after stem cell transplantationHolger Hebart, Hermann Einsele
Annals of Internal Medicine|October 18, 2016
Nivolumab for Refractory Anaplastic Large Cell Lymphoma: A Case ReportHolger Hebart, Peter Lang, Wilhelm Woessmann
Current Opinion in Infectious Diseases|April 20, 2002
Molecular methods in the diagnosis of infections in the immunocompromised hostHolger Hebart, Juergen Loeffler, Lothar Kanz, et al.
Journal of Clinical Microbiology|May 31, 2002
Automated extraction of genomic DNA from medically important yeast species and filamentous fungi by using the MagNA Pure LC systemJuergen Loeffler, Kathrin Schmidt, Holger Hebart, et al.
Herpes : the Journal of the IHMF|February 28, 2002
CMV Infection in Bone Marrow and Solid Organ Transplant Patients in the Era of Antiviral ProphylaxisHolger Hebart, Gerhard Jahn, Christian Sinzger, et al.
Leukemia & Lymphoma|October 21, 2005
Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemiaStefan Knop, Ulrich Herrlinger, Ulrike Ernemann, et al.
Journal of Neurology|May 17, 2005
Relapse of primary CNS lymphoma after more than 10 years in complete remissionUlrich Herrlinger, Holger Hebart, Lothar Kanz, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Current Opinion in Hematology|October 24, 2002
Cellular immunity to viral and fungal antigens after stem cell transplantationHermann Einsele, Holger Hebart
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 16, 2003
Specific infectious complications after stem cell transplantationHolger Hebart, Hermann Einsele
Human Immunology|June 3, 2004
CMV-specific immunotherapyHermann Einsele, Holger Hebart
Human Immunology|June 3, 2004
Clinical aspects of CMV infection after stem cell transplantationHolger Hebart, Hermann Einsele
Annals of Internal Medicine|October 18, 2016
Nivolumab for Refractory Anaplastic Large Cell Lymphoma: A Case ReportHolger Hebart, Peter Lang, Wilhelm Woessmann
Current Opinion in Infectious Diseases|April 20, 2002
Molecular methods in the diagnosis of infections in the immunocompromised hostHolger Hebart, Juergen Loeffler, Lothar Kanz, et al.
Journal of Clinical Microbiology|May 31, 2002
Automated extraction of genomic DNA from medically important yeast species and filamentous fungi by using the MagNA Pure LC systemJuergen Loeffler, Kathrin Schmidt, Holger Hebart, et al.
Herpes : the Journal of the IHMF|February 28, 2002
CMV Infection in Bone Marrow and Solid Organ Transplant Patients in the Era of Antiviral ProphylaxisHolger Hebart, Gerhard Jahn, Christian Sinzger, et al.
Leukemia & Lymphoma|October 21, 2005
Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemiaStefan Knop, Ulrich Herrlinger, Ulrike Ernemann, et al.
Journal of Neurology|May 17, 2005
Relapse of primary CNS lymphoma after more than 10 years in complete remissionUlrich Herrlinger, Holger Hebart, Lothar Kanz, et al.
Pageof 8